BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26248294)

  • 1. State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.
    Sheng C; Dong G; Miao Z; Zhang W; Wang W
    Chem Soc Rev; 2015 Nov; 44(22):8238-59. PubMed ID: 26248294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors.
    Li B; Rong D; Wang Y
    Curr Top Med Chem; 2019; 19(21):1872-1876. PubMed ID: 31696799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening.
    Mady ASA; Liao C; Bajwa N; Kump KJ; Abulwerdi FA; Lev KL; Miao L; Grigsby SM; Perdih A; Stuckey JA; Du Y; Fu H; Nikolovska-Coleska Z
    Sci Rep; 2018 Jul; 8(1):10210. PubMed ID: 29976942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors.
    Levoin N; Vo DD; Gautier F; Barillé-Nion S; Juin P; Tasseau O; Grée R
    Bioorg Med Chem; 2015 Apr; 23(8):1747-57. PubMed ID: 25797160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors.
    Sable R; Jois S
    Molecules; 2015 Jun; 20(6):11569-603. PubMed ID: 26111183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules.
    Demirel HC; Dogan T; Tuncbag N
    Curr Top Med Chem; 2018; 18(8):700-713. PubMed ID: 29852872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting protein-protein interactions and fragment-based drug discovery.
    Valkov E; Sharpe T; Marsh M; Greive S; Hyvönen M
    Top Curr Chem; 2012; 317():145-79. PubMed ID: 22006238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Space Overlap with Critical Protein-Protein Interface Residues in Commercial and Specialized Small-Molecule Libraries.
    Si Y; Xu D; Bum-Erdene K; Ghozayel MK; Yang B; Clemons PA; Meroueh SO
    ChemMedChem; 2019 Jan; 14(1):119-131. PubMed ID: 30548204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of selective small-molecule inhibitors for β-catenin/B-cell lymphoma 9 protein-protein interactions.
    Hoggard LR; Zhang Y; Zhang M; Panic V; Wisniewski JA; Ji H
    J Am Chem Soc; 2015 Sep; 137(38):12249-60. PubMed ID: 26352795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and screening of small-molecule α-helix mimetic libraries targeting protein-protein interactions.
    Moon H; Lim HS
    Curr Opin Chem Biol; 2015 Feb; 24():38-47. PubMed ID: 25461722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
    Shin WH; Christoffer CW; Kihara D
    Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico design of low molecular weight protein-protein interaction inhibitors: Overall concept and recent advances.
    Kuenemann MA; Sperandio O; Labbé CM; Lagorce D; Miteva MA; Villoutreix BO
    Prog Biophys Mol Biol; 2015 Oct; 119(1):20-32. PubMed ID: 25748546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions.
    Laraia L; McKenzie G; Spring DR; Venkitaraman AR; Huggins DJ
    Chem Biol; 2015 Jun; 22(6):689-703. PubMed ID: 26091166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting epigenetic protein-protein interactions with small-molecule inhibitors.
    Linhares BM; Grembecka J; Cierpicki T
    Future Med Chem; 2020 Jul; 12(14):1305-1326. PubMed ID: 32551894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.
    Arkin MR; Tang Y; Wells JA
    Chem Biol; 2014 Sep; 21(9):1102-14. PubMed ID: 25237857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating Protein-protein Interactions Through Computational Approaches and Designing Small Molecule Inhibitors Against them for Various Diseases.
    Sarkar S; Gulati K; Kairamkonda M; Mishra A; Poluri KM
    Curr Top Med Chem; 2018; 18(20):1719-1736. PubMed ID: 30360722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving small molecule virtual screening strategies for the next generation of therapeutics.
    Wingert BM; Camacho CJ
    Curr Opin Chem Biol; 2018 Jun; 44():87-92. PubMed ID: 29920436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.